Further genomic studies are necessary in order to define the prognostic and predictive role of CDKN2A/B mutations in CCA setting, and in order to explicate the different role revealed in IDH1m and IDH1wt patients in our analysis. Here, CDKN2A is linked to cholangiocarcinoma.